Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4760397 | 0.85 | — | — | |
| SCHEMBL13416816 | 0.83 | EPHX1 (0.40) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL16169031 | 0.83 | EPHX1 (0.40) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL14299180 | 0.83 | EPHX1 (0.40) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL16316581 | 0.83 | EPHX1 (0.40) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL1900865 | 0.82 | EPHX1 (0.48) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL646456 | 0.82 | EPHX1 (0.48) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL3293988 | 0.82 | EPHX1 (0.48) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL29257688 | 0.82 | EPHX1 (0.48) | EPHX1SHBGDPP4TP53KDM4E | |
| SCHEMBL1900915 | 0.82 | EPHX1 (0.48) | EPHX1SHBGDPP4TP53KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106458883-A | Chlorine resistant polyethylene compounds and articles made therefrom | 弗纳技术股份有限公司 | 2017-02-22 | — | — | CN | claimed |
| EP-4556101-A1 | GAS REMOVAL METHOD | Evonik Operations GmbH (DE) | 2025-05-21 | — | — | EP | disclosed |
| CN-120019859-A | Method for removing gas | 赢创运营有限公司 | 2025-05-20 | — | — | CN | disclosed |
| US-20210277175-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2021-09-09 | — | — | US | disclosed |
| US-11046809-B2 | Amine for low-emission epoxy resin compositions | SIKA TECHNOLOGY AG (CH) | 2021-06-29 | — | — | US | disclosed |
| CN-108124448-B | Amines for low emission epoxy resin compositions | SIKA技术股份公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-3350245-B1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECH AG (CH) | 2019-08-14 | — | — | EP | disclosed |
| US-20190002628-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2019-01-03 | — | — | US | disclosed |
| EP-3350245-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2018-07-25 | — | — | EP | disclosed |
| WO-2017046292-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2017-03-23 | — | — | WO | disclosed |
| EP-3144335-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2017-03-22 | — | — | EP | disclosed |
| CN-106458883-A | Chlorine resistant polyethylene compounds and articles made therefrom | 弗纳技术股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-1807078-A1 | DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| US-20070066624-A1 | Chemokine receptor binding compounds | ANORMED, INC. (CA) | 2007-03-22 | — | — | US | disclosed |
| WO-2006042150-A1 | DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| US-4284775-A | 1,4-Diazabicyclooctane di-N,N'-quaternized compounds | THE UPJOHN COMPANY (US) | 1981-08-18 | — | — | US | disclosed |
| US-4216322-A | Process for making triethylene diamines | THE UPJOHN COMPANY (US) | 1980-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | CCR5, CCR4, CCR1 | EPHX1 1750/4885SHBG 2124/4885DPP4 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.